Special Issue "Advances in Diagnosis and Management of Venous Thromboembolic Disorders"
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Vascular Medicine".
Deadline for manuscript submissions: 20 August 2023 | Viewed by 2520
Special Issue Editors
Interests: acute and chronic venous diseases; carotid surgery (paraganglioma); aortic surgery (systemic inflammatory response)
Interests: venous thromboembolism; thrombophilia; cancer-associated thrombosis; direct oral anticoagulants
Special Issue Information
Dear Colleagues,
Venous thromboembolic disorders are a set of clinical states —pulmonary embolism, deep-vein thrombosis (DVT) and superficial, post-thrombotic syndrome, etc.— all of which are permanent hot topics. Their frequency and impact on morbidity and mortality, and their social implications (altered quality of life) and economic burdens on health systems attest to this.
On the other hand, venous thromboembolic diseases create a cross-cutting clinical situation because they affect numerous medical and surgical specialities. This, along with the vast amount of research and innovation regarding these issues, makes VTDs one of the most frequent topics in the medical literature. As if all this were not enough, the interruption due to COVID-19 has given an even greater impetus—if that were possible—to medical research on the conditions and their social impact. In this sense, the etiopathogenesis of VTDs is under permanent review. Our diagnostic and therapeutic knowledge about venous thromboembolic disease is very extensive and constantly evolving. A good example of this is the case of DVT, for which the historical therapeutic pendulum, swinging between antithrombotics and thrombectomies, has recently been analysed and updated. Finally, the outpatient treatment of most of these disorders has allowed a before and after in the management of these diseases.
Dr. Francisco S. Lozano Sánchez
Dr. José Ramón González-Porras
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pulmonary embolism
- deep venous thrombosis
- superficial venous thrombosis
- post-thrombotic syndrome for thrombophilia
- COVID thrombosis
- cancer-associated thrombosis
- risk assessment models of thrombosis
- direct oral anticoagulants (DOACs)
- percutaneous venous thrombectomy
- vein thrombosis ambulatory treatment
- quality of life and cost-effectiveness of the prevention and treatment of deep-vein thrombosis and pulmonary embolism
